Stichting Centre for Human Drug Research

Stichting Centre for Human Drug Research is an SME in Leiden, Netherlands that has taken part in 8 EU-funded projects since 2013, receiving €6.5M in EU funding.

EU funding received€6.5M
EU projects8
As coordinator0
Running now4
First EU project2013
Latest project2026
CountryNetherlands
EU registration (PIC)951135926
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Stichting Centre for Human Drug Research's own share of each project, not the project's full budget.

  • Horizon Europe€3.5M · 3 projects
  • Horizon 2020€2.3M · 4 projects
  • FP7 (2007 to 2013)€731k · 1 project

Projects

8 EU-funded projects, newest first. Each links to the official record.

  • SOL-116 - BEYONDPartner

    BSSL TARGETING THERAPY TOWARDS NON-IMMUNOSUPPRESSIVE RA TREATMENT

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €254ktheir share
  • INTEGRATEAssociated partner

    INTEGRATE - Interdisciplinary Network for Training, Education, and Growing Research into Applications of and Therapeutic Expertise around Psychedelics

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • FLUniversalPartner

    Intranasal, rapid-acting vaccine for all seasonal and pandemic influenza viruses

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €3.3Mtheir share
  • Inno4VacPartner

    Innovations to accelerate vaccine development and manufacture

    Horizon 2020 · 2021–2028 · Project on CORDIS ↗

    €1.6Mtheir share
  • INCENTIVEAssociated partner

    Indo-European Consortium for Next Generation Influenza Vaccine Innovation

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

  • QSPainReliefPartner

    Effective combinational treatment of chronic pain in individual patients, by an innovative quantitative systems pharmacology pain relief approach.

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €678ktheir share
  • TAcTICPartner

    TArgeTed molecular Imaging and surgery for gastro-intestinal Cancer

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €21ktheir share
  • VIAPartner

    Vaccination In Atherosclerosis

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €731ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • arteriosclerosis
  • big data
  • biomolecules
  • immunology
  • influenza
  • mathematical model
  • nucleic acids
  • oncology
  • pathology
  • personalized medicine
  • pharmacokinetics
  • primatology
  • rheumatology
  • surgery

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime